Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Rangering i aksjer #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Aksjekurs
$44.42
Sist synkronisert: 2026-08-25
Markedsverdi
$5.90B
Endring (1 dag)
2.66%
Endring (1 år)
344.66%
Land
US
Handel Definium Therapeutics, Inc. (DFTX)

Kategori

Historikk for aksjesplitt for Definium Therapeutics, Inc. (DFTX)
Aksjen Definium Therapeutics, Inc. (symbol: DFTX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 26, 2026.
Én DFTX-aksje kjøpt før Aug 26, 2026 tilsvarer i dag 0 DFTX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH